ORBIMED ADVISORS LLC Arcutis Biotherapeutics, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$53.50M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

-10.32%
quarter

Arcutis Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -41.44% -1.98M shares -48.38M $19.11 2.8M
Q2 2022 share Decrease -21.27% -1.29M shares -15.08M $21.31 4.78M
Q1 2022 share 0.00% 0 shares -8.99M $19.26 6.07M
Q4 2021 share 0.00% 0 shares -19.13M $20.48 6.07M
Q3 2021 share 0.00% 0 shares -20.65M $23.89 6.07M
Q2 2021 share 0.00% 0 shares -9.96M $27.29 6.07M
Q1 2021 share 0.00% 0 shares 4.85M $28.93 6.07M
Q4 2020 share Increase +29.95% 1.4M shares 33.91M $28.13 6.07M
Q3 2020 share 0.00% 0 shares -4.39M $29.3 4.67M
Q2 2020 share 0.00% 0 shares 2.05M $30.24 4.67M
Q1 2020 share Increase 0.00% 4.67M shares 139.28M $29.8 4.67M